Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Paul Bédard

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Macaca fascicularis

Chemicals & Drugs

Disorders

Anatomy

Corpus Striatum

Activities & Behaviors

Procedures

Ovariectomy

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
55
Di Paolo, Thérèse
26
Calon, Frederic
25
Grégoire, Laurent
25
Grondin, Richard
24
Morissette, Marc
22
Blanchet, Pierre
20
Goulet, Marlyne
18
Hadj Tahar, Abdallah
14
Samadi, Pershia
9
Rouillard, Claude
7
Falardeau, P
7
Bélanger, Nancy
6
Dridi, Mehdi
6
Rajput, Ali
6
Meltzer, Leonard

Sign-in to see all Coauthors

Publications

TOP 3
Grégoire Laurent; Samadi Pershia; Graham Julie; Bédard Paul J; Bartoszyk Gerd D; Di Paolo Thérèse
Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of L-Dopa in parkinsonian monkeys.
Samadi Pershia; Grégoire Laurent; Morissette Marc; Calon Fréderic; Hadj Tahar Abdallah; Dridi Mehdi; Belanger Nancy; Meltzer Leonard T; Bédard Paul J; Di Paolo Thérèse
mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys.
Samadi Pershia; Grégoire Laurent; Morissette Marc; Calon Fréderic; Hadj Tahar Abdallah; Bélanger Nancy; Dridi Mehdi; Bédard Paul J; Di Paolo Thérèse
Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Paul Bédard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Grégoire Laurent; Samadi Pershia; Graham Julie; Bédard Paul J; Bartoszyk Gerd D; Di Paolo Thérèse
Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of L-Dopa in parkinsonian monkeys.
Parkinsonism & related disorders 2009;15(6):445-52.
2008: Samadi Pershia; Grégoire Laurent; Morissette Marc; Calon Fréderic; Hadj Tahar Abdallah; Dridi Mehdi; Belanger Nancy; Meltzer Leonard T; Bédard Paul J; Di Paolo Thérèse
mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys.
Neurobiology of aging 2008;29(7):1040-51.
2008: Samadi Pershia; Grégoire Laurent; Morissette Marc; Calon Fréderic; Hadj Tahar Abdallah; Bélanger Nancy; Dridi Mehdi; Bédard Paul J; Di Paolo Thérèse
Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias.
Neuropharmacology 2008;54(2):258-68.
2008: Samadi Pershia; Morissette Marc; Calon Fréderic; Hadj Tahar Abdallah; Dridi Mehdi; Belanger Nancy; Meltzer Leonard T; Bédard Paul J; Di Paolo Thérèse
Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L-dopa-induced dyskinesias in MPTP parkinsonian monkeys.
Synapse (New York, N.Y.) 2008;62(2):101-9.
2008: Grégoire Laurent; Rassoulpour Arash; Guidetti Paolo; Samadi Pershia; Bédard Paul J; Izzo Emanuela; Schwarcz Robert; Di Paolo Thérèse
Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.
Behavioural brain research 2008;186(2):161-7.
2007: Samadi Pershia; Rouillard Claude; Bédard Paul J; Di Paolo Thérèse
Functional neurochemistry of the basal ganglia.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2007;83():19-66.
2006: Bélanger Nancy; Grégoire Laurent; Bédard Paul J; Di Paolo Thérèse
DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys.
Neurobiology of aging 2006;27(11):1684-93.
2006: Samadi Pershia; Bédard Paul J; Rouillard Claude
Opioids and motor complications in Parkinson's disease.
Trends in pharmacological sciences 2006;27(10):512-7.
2006: Morissette Marc; Dridi Mehdi; Calon Frédéric; Hadj Tahar Abdallah; Meltzer Leonard T; Bédard Paul J; Di Paolo Thérèse
Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
Synapse (New York, N.Y.) 2006;60(3):239-50.
2006: Julien Carl; Berthiaume Line; Hadj-Tahar Abdallah; Rajput Ali H; Bédard Paul J; Di Paolo Thérèse; Julien Pierre; Calon Frédéric
Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys.
Neurochemistry international 2006;48(5):404-14.
2006: Samadi Pershia; Grégoire Laurent; Rouillard Claude; Bédard Paul J; Di Paolo Thérèse; Lévesque Daniel
Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
Annals of neurology 2006;59(2):282-8.
2006: Morissette Marc; Dridi Mehdi; Calon Frédéric; Hadj Tahar Abdallah; Meltzer Leonard T; Bédard Paul J; Di Paolo Thérèse
Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
Movement disorders : official journal of the Movement Disorder Society 2006;21(1):9-17.
2005: Samadi Pershia; Grégoire Laurent; Hadj Tahar Abdallah; Di Paolo Thérèse; Rouillard Claude; Bédard Paul J
Naltrexone in the short-term decreases antiparkinsonian response to l-Dopa and in the long-term increases dyskinesias in drug-naïve parkinsonian monkeys.
Neuropharmacology 2005;49(2):165-73.
2005: Samadi Pershia; Grégoire Laurent; Rassoulpour Arash; Guidetti Paolo; Izzo Emanuela; Schwarcz Robert; Bédard Paul J
Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys.
Movement disorders : official journal of the Movement Disorder Society 2005;20(7):792-802.
2005: Samadi Pershia; Grégoire Laurent; Rouillard Claude; Bédard Paul J
Dyskinesias occur in response to saline and naltrexone alone after priming with combination of dopaminergic agents and naltrexone in the MPTP parkinsonian monkeys.
Neurobiology of disease 2005;19(1-2):266-72.
2004: Blanchet Pierre J; Calon Frédéric; Morissette Marc; Hadj Tahar Abdallah; Bélanger Nancy; Samadi Pershia; Grondin Richard; Grégoire Laurent; Meltzer Leonard; Di Paolo Thérèse; Bédard Paul J
Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms.
Parkinsonism & related disorders 2004;10(5):297-304.
2004: Samadi Pershia; Grégoire Laurent; Bédard Paul J
The opioid agonist morphine decreases the dyskinetic response to dopaminergic agents in parkinsonian monkeys.
Neurobiology of disease 2004;16(1):246-53.
2004: Calon Frédéric; Dridi Mehdi; Hornykiewicz Oleh; Bédard Paul J; Rajput Ali H; Di Paolo Thérèse
Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.
Brain : a journal of neurology 2004;127(Pt 5):1075-84.
2004: Hadj Tahar Abdallah; Grégoire Laurent; Darré Aurélie; Bélanger Nancy; Meltzer Leonard; Bédard Paul J
Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys.
Neurobiology of disease 2004;15(2):171-6.
2003: Hadj Tahar A; Bézard E; Grondin R; Gross C E; Bédard P J
[Pathophysiology and therapy of L-Dopa-induced dyskinesia]
Revue neurologique 2003;159(12):1125-42.
2003: Calon Frédéric; Rajput Ali H; Hornykiewicz Oleh; Bédard Paul J; Di Paolo Thérèse
Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease.
Neurobiology of disease 2003;14(3):404-16.
2003: Bélanger Nancy; Grégoire Laurent; Hadj Tahar Abdallah; Bédard Paul J
Chronic treatment with small doses of cabergoline prevents dopa-induced dyskinesias in parkinsonian monkeys.
Movement disorders : official journal of the Movement Disorder Society 2003;18(12):1436-41.
2003: Samadi Pershia; Grégoire Laurent; Bédard Paul J
Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems.
Neuropharmacology 2003;45(7):954-63.
2003: Bélanger Nancy; Grégoire Laurent; Bédard Paul; Di Paolo Thérèse
Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
Endocrine 2003;21(1):97-101.
2003: Calon Frédéric; Morissette Marc; Rajput Ali H; Hornykiewicz Oleh; Bédard Paul J; Di Paolo Thérèse
Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications.
Movement disorders : official journal of the Movement Disorder Society 2003;18(3):241-53.
2003: Hadj Tahar A; Grondin R; Grégoire L; Calon F; Di Paolo T; Bédard P J
New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
Advances in neurology 2003;91():51-64.
2002: Calon Frédéric; Birdi Sam; Rajput Ali H; Hornykiewicz Oleh; Bédard Paul J; Di Paolo Thérèse
Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias.
Journal of neuropathology and experimental neurology 2002;61(2):186-96.
2002: Calon Frédéric; Morissette Marc; Ghribi Othman; Goulet Martin; Grondin Richard; Blanchet Pierre J; Bédard Paul J; Di Paolo Thérèse
Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(1):127-38.
2001: Tekumalla P K; Calon F; Rahman Z; Birdi S; Rajput A H; Hornykiewicz O; Di Paolo T; Bédard P J; Nestler E J
Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease.
Biological psychiatry 2001;50(10):813-6.
2001: Calon F; Lavertu N; Lemieux A M; Morissette M; Goulet M; Grondin R; Blanchet P J; Bédard P J; Di Paolo T
Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
Synapse (New York, N.Y.) 2001;40(3):225-34.
2001: Hadj Tahar A; Ekesbo A; Grégoire L; Bangassoro E; Svensson K A; Tedroff J; Bédard P J
Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on L-DOPA-induced dyskinesias in MPTP monkeys.
European journal of pharmacology 2001;412(3):247-54.
2001: Blanchet P J; Calon F; Morissette M; Goulet M; Grondin R; Lévesque D; Bédard P J; Di Paolo T
Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model.
Advances in neurology 2001;86():337-44.
2000: Calon F; Hadj Tahar A; Blanchet P J; Morissette M; Grondin R; Goulet M; Doucet J P; Robertson G S; Nestler E; Di Paolo T; Bédard P J
Dopamine-receptor stimulation: biobehavioral and biochemical consequences.
Trends in neurosciences 2000;23(10 Suppl):S92-100.
2000: Hadj Tahar A; Grégoire L; Bangassoro E; Bédard P J
Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys.
Clinical neuropharmacology 2000;23(4):195-202.
2000: Hadj Tahar A; Bélanger N; Bangassoro E; Grégoire L; Bédard P J
Antidyskinetic effect of JL-18, a clozapine analog, in parkinsonian monkeys.
European journal of pharmacology 2000;399(2-3):183-6.
2000: Goulet M; Grondin R; Morissette M; Maltais S; Falardeau P; Bédard P J; Di Paolo T
Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys.
Progress in neuro-psychopharmacology & biological psychiatry 2000;24(4):607-17.
2000: Calon F; Morissette M; Goulet M; Grondin R; Blanchet P J; Bédard P J; Di Paolo T
125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
Experimental neurology 2000;163(1):191-9.
2000: Calon F; Grondin R; Morissette M; Goulet M; Blanchet P J; Di Paolo T; Bédard P J
Molecular basis of levodopa-induced dyskinesias.
Annals of neurology 2000;47(4 Suppl 1):S70-8.
2000: Grondin R; Hadj Tahar A; Doan V D; Ladure P; Bédard P J
Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys.
Naunyn-Schmiedeberg's archives of pharmacology 2000;361(2):181-6.
1999: Doan V D; Grondin R; Hadj Tahar A; Grégoire L; Bédard P J
Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys.
Clinical neuropharmacology 1999;22(5):281-7.
1999: Grondin R; Goulet M; Morissette M; Bédard P J; Di Paolo T
Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958.
European journal of pharmacology 1999;378(3):259-63.
1999: Calon F; Morissette M; Goulet M; Grondin R; Blanchet P J; Bédard P J; Di Paolo T
Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA content.
Neurochemistry international 1999;35(1):81-91.
1999: Goulet M; Morissette M; Grondin R; Falardeau P; Bédard P J; Rostène W; Di Paolo T
Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Synapse (New York, N.Y.) 1999;32(3):153-64.
1999: Grondin R; Bédard P J; Hadj Tahar A; Grégoire L; Mori A; Kase H
Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys.
Neurology 1999;52(8):1673-7.
1999: Grondin R; Doan V D; Grégoire L; Bédard P J
D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys.
Neurology 1999;52(4):771-6.
1999: Morissette M; Grondin R; Goulet M; Bédard P J; Di Paolo T
Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists.
Journal of neurochemistry 1999;72(2):682-92.
1999: Bédard P J; Blanchet P J; Lévesque D; Soghomonian J J; Grondin R; Morissette M; Goulet M; Calon F; Falardeau P; Gomez-Mancilla B; Doucet J P; Robertson G S; DiPaolo T
Pathophysiology of L-dopa-induced dyskinesias.
Movement disorders : official journal of the Movement Disorder Society 1999;14 Suppl 1():4-8.
1998: Hadj Tahar A; Bédard P J
[Understanding and treating levodopa-induced dyskinesias]
La Tunisie médicale 1998;76(12):437-47.
1998: Morissette M; Goulet M; Grondin R; Blanchet P; Bédard P J; Di Paolo T; Lévesque D
Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies.
The European journal of neuroscience 1998;10(8):2565-73.
1997: Morissette M; Goulet M; Soghomonian J J; Blanchet P J; Calon F; Bédard P J; Di Paolo T
Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.
Brain research. Molecular brain research 1997;49(1-2):55-62.
1997: Grondin R; Bédard P J; Britton D R; Shiosaki K
Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys.
Neurology 1997;49(2):421-6.
1997: Goulet M; Morissette M; Calon F; Blanchet P J; Falardeau P; Bédard P J; Di Paolo T
Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis.
Neuroscience 1997;79(2):497-507.
1996: Morissette M; Goulet M; Calon F; Falardeau P; Blanchet P J; Bédard P J; Di Paolo T
Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.
Molecular pharmacology 1996;50(5):1073-9.
1996: Grondin R; Goulet M; Di Paolo T; Bédard P J
Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates.
Brain research 1996;735(2):298-306.
1996: Blanchet P J; Grondin R; Bédard P J; Shiosaki K; Britton D R
Dopamine D1 receptor desensitization profile in MPTP-lesioned primates.
European journal of pharmacology 1996;309(1):13-20.
1996: Blanchet P J; Allard P; Grégoire L; Tardif F; Bédard P J
Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1996;23(3):189-93.
1996: Soghomonian J J; Pedneault S; Blanchet P J; Goulet M; Di Paolo T; Bédard P J
L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys.
Brain research. Molecular brain research 1996;39(1-2):237-40.
1996: Goulet M; Grondin R; Blanchet P J; Bédard P J; Di Paolo T
Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys.
Brain research 1996;719(1-2):129-37.
1996: Blanchet P J; Grondin R; Bédard P J
Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.
Movement disorders : official journal of the Movement Disorder Society 1996;11(1):91-4.
1995: Bédard P J
D-1 receptors in neurology and psychiatry an overview.
Progress in neuro-psychopharmacology & biological psychiatry 1995;19(5):713-26.
1995: Gagnon C; Gomez-Mancilla B; Markstein R; Bédard P J; Di Paolo T
Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptors.
Progress in neuro-psychopharmacology & biological psychiatry 1995;19(4):667-76.
1995: Calon F; Goulet M; Blanchet P J; Martel J C; Piercey M F; Bédard P J; Di Paolo T
Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
Brain research 1995;680(1-2):43-52.
1995: Petitclerc M; Bédard P J; Di Paolo T
Progesterone releases dopamine in male and female rat striatum: a behavioral and microdialysis study.
Progress in neuro-psychopharmacology & biological psychiatry 1995;19(3):491-7.
1995: Roy E; Côté P Y; Grégoire L; Parent A; Bédard P J
Mesencephalic grafts partially restore normal nigral dynorphin levels in 6-hydroxydopamine-lesioned rats treated chronically with L-dihydroxyphenylalanine.
Neuroscience 1995;66(2):413-25.
1995: Blanchet P J; Calon F; Martel J C; Bédard P J; Di Paolo T; Walters R R; Piercey M F
Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.
The Journal of pharmacology and experimental therapeutics 1995;272(2):854-9.
1995: St-Pierre J A; Bédard P J
Systemic administration of the NMDA receptor antagonist MK-801 potentiates circling induced by intrastriatal microinjection of dopamine.
European journal of pharmacology 1995;272(2-3):123-9.
1995: Blanchet P J; Gomez-Mancilla B; Bédard P J
DOPA-induced "peak dose" dyskinesia: clues implicating D2 receptor-mediated mechanisms using dopaminergic agonists in MPTP monkeys.
Journal of neural transmission. Supplementum 1995;45():103-12.
1995: Blanchet P J; Gomez-Mancilla B; Di Paolo T; Bédard P J
Is striatal dopaminergic receptor imbalance responsible for levodopa-induced dyskinesia?
Fundamental & clinical pharmacology 1995;9(5):434-42.
1994: St-Pierre J A; Bédard P J
Intranigral but not intrastriatal microinjection of the NMDA antagonist MK-801 induces contralateral circling in the 6-OHDA rat model.
Brain research 1994;660(2):255-60.
1994: Blanchet P J; Boucher R; Bédard P J
Excitotoxic lateral pallidotomy does not relieve L-dopa-induced dyskinesia in MPTP parkinsonian monkeys.
Brain research 1994;650(1):32-9.
1994: Gaudin D P; St-Pierre J A; Lavoie B; Bédard P J
Transsynaptic effect of an intrastriatal fetal nigral graft on the sensitivity of the substantia nigra pars reticulata to muscimol in the rat.
Experimental neurology 1994;127(1):45-53.
1993: Gagnon C; Gomez-Mancilla B; Bédard P J; Di Paolo T
Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors.
Neuroscience letters 1993;163(1):31-5.
1993: Gomez-Mancilla B; Bédard P J
Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.
Clinical neuropharmacology 1993;16(5):418-27.
1993: Blanchet P; Bédard P J; Britton D R; Kebabian J W
Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- exposed monkeys.
The Journal of pharmacology and experimental therapeutics 1993;267(1):275-9.
1993: Rioux L; Gagnon C; Gaudin D P; Di Paolo T; Bédard P J
A fetal nigral graft prevents behavioral supersensitivity associated with repeated injections of L-dopa in 6-OHDA rats. Correlation with D1 and D2 receptors.
Neuroscience 1993;56(1):45-51.
1993: Gomez-Mancilla B; Boucher R; Gagnon C; Di Paolo T; Markstein R; Bédard P J
Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.
Movement disorders : official journal of the Movement Disorder Society 1993;8(2):144-50.
1993: Gagnon C; Bédard P J; Di Paolo T
Grafts in the treatment of Parkinson's disease: animal models.
Reviews in the neurosciences 1993;4(1):17-40.
1993: Bédard P J; Gomez-Mancilla B; Blanchette P; Gagnon C; Falardeau P; DiPaolo T
Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys.
Advances in neurology 1993;60():113-8.
1992: Gomez-Mancilla B; Bédard P J
Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys.
Experimental neurology 1992;117(2):185-8.
1992: Bédard P J; Mancilla B G; Blanchette P; Gagnon C; Di Paolo T
Levodopa-induced dyskinesia: facts and fancy. What does the MPTP monkey model tell us?
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1992;19(1 Suppl):134-7.
1992: Gomez-Mancilla B; Bédard P J
Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTP-treated monkeys.
Neuroscience letters 1992;135(1):129-32.
1992: Gomez-Mancilla B; Latulippe J F; Boucher R; Bédard P J
Effect of ethosuximide on rest tremor in the MPTP monkey model.
Movement disorders : official journal of the Movement Disorder Society 1992;7(2):137-41.
1992: Pourcher E; Gomez-Mancilla B; Bédard P J
Ethosuximide and tremor in Parkinson's disease: a pilot study.
Movement disorders : official journal of the Movement Disorder Society 1992;7(2):132-6.
1992: Gomez-Mancilla B; Boucher R; Bédard P J
Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
Movement disorders : official journal of the Movement Disorder Society 1992;7(1):43-7.
1991: Gomez-Mancilla B; Bédard P J
Effect of D1 and D2 agonists and antagonists on dyskinesia produced by L-dopa in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
The Journal of pharmacology and experimental therapeutics 1991;259(1):409-13.
1991: Gagnon C; Bédard P J; Rioux L; Gaudin D; Martinoli M G; Pelletier G; Di Paolo T
Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
Brain research 1991;558(2):251-63.
1991: Lavoie B; Parent A; Bédard P J
Effects of dopamine denervation on striatal peptide expression in parkinsonian monkeys.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1991;18(3 Suppl):373-5.
1991: Gomez-Mancilla B; Boucher R; Bédard P J
Effect of clonidine and atropine on rest tremor in the MPTP monkey model of parkinsonism.
Clinical neuropharmacology 1991;14(4):359-66.
1991: Filion M; Tremblay L; Bédard P J
Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism.
Brain research 1991;547(1):152-61.
1991: Rioux L; Gaudin D P; Bui L K; Grégoire L; DiPaolo T; Bédard P J
Correlation of functional recovery after a 6-hydroxydopamine lesion with survival of grafted fetal neurons and release of dopamine in the striatum of the rat.
Neuroscience 1991;40(1):123-31.
1991: Rioux L; Gaudin D P; Gagnon C; Di Paolo T; Bédard P J
Decrease of behavioral and biochemical denervation supersensitivity of rat striatum by nigral transplants.
Neuroscience 1991;44(1):75-83.
1990: Rouillard C; Bédard P J; Di Paolo T
Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
European journal of pharmacology 1990;185(2-3):209-15.
1990: Gagnon C; Bédard P J; Di Paolo T
Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists.
European journal of pharmacology 1990;178(1):115-20.
1990: Gaudin D P; Rioux L; Bédard P J
Fetal dopamine neuron transplants prevent behavioral supersensitivity induced by repeated administration of L-dopa in the rat.
Brain research 1990;506(1):166-8.
1989: Tremblay L; Filion M; Bédard P J
Responses of pallidal neurons to striatal stimulation in monkeys with MPTP-induced parkinsonism.
Brain research 1989;498(1):17-33.
1989: Di Paolo T; Rouillard C; Morissette M; Lévesque D; Bédard P J
Endocrine and neurochemical actions of cocaine.
Canadian journal of physiology and pharmacology 1989;67(9):1177-81.
1989: Tremblay L E; Bédard P J
Chronic administration of thyrotropin-releasing hormone enhances the sensitivity of lumbar motoneurons to 5-hydroxytryptophan in the rat.
Pharmacology, biochemistry, and behavior 1989;33(1):127-30.
1989: Di Paolo T; Bédard F; Bédard P J
Influence of gonadal steroids on human and monkey cerebrospinal fluid homovanillic acid concentrations.
Clinical neuropharmacology 1989;12(1):60-6.
1988: Rouillard C; Bédard P J
Specific D1 and D2 dopamine agonists have synergistic effects in the 6-hydroxydopamine circling model in the rat.
Neuropharmacology 1988;27(12):1257-64.
1988: Bédard P J; Boucher R; DiPaolo T
[Animal models of tardive dyskinesia]
L'Encéphale 1988;14 Spec No():163-6.
1988: Falardeau P; Bouchard S; Bédard P J; Boucher R; Di Paolo T
Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.
European journal of pharmacology 1988;150(1-2):59-66.
1988: Filion M; Tremblay L; Bédard P J
Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys.
Brain research 1988;444(1):165-76.
1988: Falardeau P; Bédard P J; Di Paolo T
Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys.
Neuroscience letters 1988;86(2):225-9.
1987: Rouillard C; Bédard P J; Falardeau P; Dipaolo T
Behavioral and biochemical evidence for a different effect of repeated administration of L-dopa and bromocriptine on denervated versus non-denervated striatal dopamine receptors.
Neuropharmacology 1987;26(11):1601-6.
1987: Martel J C; St-Pierre S; Bédard P J; Quirion R
Comparison of [125I]Bolton-Hunter neuropeptide Y binding sites in the forebrain of various mammalian species.
Brain research 1987;419(1-2):403-7.
1987: Bédard P J; Tremblay L E; Barbeau H; Filion M; Maheux R; Richards C L; DiPaolo T
Action of 5-hydroxytryptamine, substance P, thyrotropin-releasing hormone and clonidine on motoneurone excitability.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1987;14(3 Suppl):506-9.
1986: Tremblay L E; Maheux R; Bédard P J
Substance P in the lumbar spinal cord of the rat affects the motor response to 5-HTP and TRH.
Neuropharmacology 1986;25(4):419-24.
1985: Tremblay L E; Bédard P J; Maheux R; Di Paolo T
Denervation supersensitivity to 5-hydroxytryptamine in the rat spinal cord is not due to the absence of 5-hydroxytryptamine.
Brain research 1985;330(1):174-7.
1983: Richards C L; Bédard P J; Fortin G; Malouin F
Quantitative evaluation of the effects of L-dopa in torsion dystonia: a case report.
Neurology 1983;33(8):1083-7.
1982: Barbeau H; Richards C L; Bédard P J
Action of cyproheptadine in spastic paraparetic patients.
Journal of neurology, neurosurgery, and psychiatry 1982;45(10):923-6.
1982: Bédard P J; Malouin F; Dipaolo T; Labrie F
Estradiol, TRH and striatal dopaminergic mechanisms.
Progress in neuro-psychopharmacology & biological psychiatry 1982;6(4-6):555-61.

Sign-in to see more